Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown,
which usually occurs with asymptomatic whitish patch or macule. Although several …

Vitiligo is a chronic, acquired depigmenting condition of the skin, and sometimes of the
mucosa, that results in the selective loss of melanocytes. 1 Vitiligo has been reported since …

Clinical Question Which interventions are associated with highest efficacy and fewest
adverse events for treating vitiligo? Bottom Line Combination therapies, particularly those …

Little is known about the functions of microRNAs (miRNAs) in skin pigmentation disorders.
The aim of this study was to investigate the expression and potential role of miRNAs in …

IL-33 is a recently identified cytokine, encoded by the IL-33 gene, which is a member of the
IL-1 family that drives the production of T-helper-2 (Th-2)-associated cytokines. Serum levels …

Abnormal skin pigmentation represents a common skin problem which may be congenitally
determined or acquired during life. The former are discussed in Chapter [70]. Acquired …

Background Various phototherapy methods are used to treat vitiligo; however, the recent
emergence of new devices has heightened debate concerning the best treatment method …

Facial vitiligo is associated with considerable psychological impact. The management is
challenging and requires multidisciplinary treatment. Adding fractional carbon dioxide (CO …

Pathogenesis of vitiligo is believed to be multifactorial disease with a wide variety of
therapeutic modalities. The aim of this work is to assess the efficacy of oral mini‐pulse …

Background: Vitiligo is an acquired idiopathic cutaneous disease characterized by pearly
white patches of variable shapes and sizes. Various medical and surgical therapeutic …